Also exemplified is the effect of a combination of an anti-CTLA4 antibody and a LTBR agonist (VHH-16) on tumor growth im an MC38 syngeneic mouse model resulting in synergism in reducing tumor burden.BERGERS, GABRIELEALLEN, ELIZABETHDOMBRECHT, BRUNO...
AN LTBR AGONIST IN COMBINATION THERAPY AGAINST CANCERThe present invention relates to a combination comprising a Treg depletor and an LTBR agonist. Such a combination is particularly useful for use in the treatment of a cancer.BERGERS, GABRIELE...